SBIR vs STTR 2026: Finding the Right Federal R&D Grant for Your Startup

SBIR/STTR

2026 US SBIR/STTR & FAST Grants: Everything You Need to Know About Non-Dilutive R&D Funding

Verified Federal Grant Information

Reviewed by: Dr. Robert Kim, Federal R&D Grant Consultant

Updated: 2026 Fiscal Year Agency Guidelines

Sources: SBIR.gov, U.S. Small Business Administration (SBA)

For Deep Tech, Biotech, and AI startups possessing innovative technologies, the most ideal source of initial R&D capital is non-dilutive funding. The US Federal Government allocates billions of dollars annually to support technological innovation and commercialization in small businesses, primarily through the SBIR (Small Business Innovation Research) and STTR (Small Business Technology Transfer) programs.

In 2026, funding limits have been raised to bolster national security and technological dominance. Furthermore, the FAST (Federal and State Technology) Partnership Program has been significantly enhanced to provide stronger matching incentives and support for underrepresented entrepreneurs.

1. SBIR vs STTR: What's the Difference?

While both programs aim to commercialize innovative technologies, the critical differences lie in the requirement for a "research institution partnership" and the primary employment of the "Principal Investigator (PI)."

• SBIR: Best suited for small businesses capable of conducting R&D internally. Outsourcing to a research institution is optional (allowed up to 33% in Phase I), and the Principal Investigator must be primarily employed by the small business.
• STTR: Requires an official partnership with a non-profit research institution (e.g., university, federal laboratory). The small business must perform at least 40% of the work, and the research institution at least 30%. This is ideal for commercializing university intellectual property or when the startup lacks sufficient internal R&D staff.

Official R&D Funding Assessment

Enter your company's current status to find the optimal federal grant track for your startup.

1. Is your company a for-profit US-based business, with at least 51% owned and controlled by US citizens or permanent residents?

This is the most critical baseline requirement for securing SBIR/STTR grants.

2. Do you plan to partner with a non-profit research institution (e.g., university) and allocate at least 30% of the overall R&D budget to them?

3. What is the current development stage of the technology you are seeking funding for?

4. Are you a Women-Owned, Minority-Owned, or Rural-based entrepreneur?

The FAST program provides priority support to underrepresented demographics and regions.

Error message.

R&D Grant Match Report

2. 2026 Phase I and Phase II Funding Caps

The programs are generally divided into two main phases based on the maturity of the technology. (Phase III is the commercialization stage, which may involve federal procurement contracts but is not directly funded by SBIR/STTR dollars.)

• Phase I (Feasibility & Concept): The objective is to establish the technical merit and commercial potential of the proposed R&D. In 2026, awards are generally up to $300,000 for 6 to 12 months.
• Phase II (R&D & Prototyping): For Phase I awardees to continue the R&D efforts initiated in Phase I. Funding is based on the results achieved. Awards are generally up to $2,000,000 for 24 months. (Caps vary slightly by agency and technology).

3. The FAST Program: Dramatically Increasing Your Win Rate

To prevent SBIR/STTR funds from being overly concentrated in specific regions like Silicon Valley or among certain demographics, the US government operates the Federal and State Technology (FAST) Partnership Program.

If you are a woman, minority, or rural entrepreneur, you can access your state's FAST organization to receive free proposal writing mentorship, business consulting, and even "Micro-grants" (matching funds) to prepare for your Phase I submission. Be sure to seek support from your local FAST partner before submitting your grant application.

Disclaimer: The report generated by this simulator is a reference tool based on the general guidelines of major federal agencies such as the Department of Defense (DoD), National Science Foundation (NSF), and National Institutes of Health (NIH) for the 2026 fiscal year. Specific funding limits, Foreign Risk Management reviews, and detailed eligibility requirements may vary by agency. Please verify your official eligibility and submit proposals directly through SBIR.gov and the respective agency's latest solicitations.